Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V31766 | OTS186935 | 2093400-18-9 | OTS186935 is a potent inhibitor of protein methyltransferase SUV39H2 with IC50 of 6.49 nM. |
![]() |
V37760 | OTS186935 triHCl | 2093401-85-3 | OTS186935 triHCl is a potent inhibitor of protein methyltransferase SUV39H2 with IC50 of 6.49 nM. |
![]() |
V38925 | OTS514 HBr | 1338544-87-8 | OTS514 HBr is a novel and highly potent inhibitor of the TOPK (T-LAK cell-originated protein kinase) with an IC50 value of 2.6 nM. |
![]() |
V30471 | OT antagonist 1 | 479080-38-1 | OT antagonist 1 (Compound 4) is a potent and specific oxytocin (Oxytocin) antagonist (inhibitor) with Ki of 50 nM. |
![]() |
V30911 | OV-1, sheep | 326855-45-2 | OV-1, sheep is an α-helical antimicrobial ovispirin peptide developed from sheep SMAP29 peptide, which can inhibit a variety of drug-resistant strains like mucinous and non-mucinous Pseudomonas aeruginosa. |
![]() |
V32738 | OVA G4 peptide | 148274-82-2 | OVA G4 peptide is a variant of the agonist ovalbumin peptide SIINFEKL (OVA) (257-264). |
![]() |
V33387 | OVA Peptide (257-264) TFA | 1262751-08-5 | OVA Peptide(257-264) TFA is the class I (Kb)-restricted peptide epitope of OVA, which is an octamer peptide that can be developed from ovalbumin presented by the class I MHC molecule H-2Kb. |
![]() |
V33022 | OVA Peptide 257-264 | 138831-86-4 | OVA Peptide(257-264) is the class I (Kb)-restricted peptide epitope of OVA, which is an octamer peptide that can be developed from ovalbumin presented by the class I MHC molecule H-2Kb. |
![]() |
V40635 | OXFBD04 | 2231747-03-6 | OXFBD04 is a potent and specific BRD4 inhibitor (antagonist) with IC50 of 166 nM. |
![]() |
V31873 | P-gp inhibitor 1 | 2050747-49-2 | P-gp inhibitor 1 is a new inhibitor that can reverse P-glycoprotein-mediated multidrug resistance. |
![]() |
V31435 | P-gp modulator 1 | 2249749-39-9 | P-gp modulator 1 is a high-affinity, orally bioavailable modulator of p-glycoprotein (Pgp) that can reverse Pgp-mediated multidrug resistance. |
![]() |
V42009 | P163-0892 | 1574576-45-6 | P163-0892 is an antifungal with strong selectivity against Cryptococcus species. |
![]() |
V39602 | P2X3 antagonist 34 | 2417288-67-4 | P2X3 antagonist 34 is a potent, selective, orally bioactive P2X3 homotrimeric receptor blocker (antagonist) with IC50s of 25 nM, 92 nM and 126 nM for human P2X3, rat P2X3 and guinea pig P2X3 receptors, respectively. |
![]() |
V31372 | P300/CBP-IN-3 | 2299226-01-8 | CBP/p300-IN-3, a p300/CBP histone acetyltransferase inhibitor, compound 6, disclosed in patent WO 2019049061 A1. |
![]() |
V30528 | p38-α MAPK-IN-1 | 443913-15-3 | p38-α MAPK-IN-1 is an inhibitor (blocker/antagonist) of MAPK14 (p38-α) with IC50s of 2300 nM and 5500 nM in EFC and HTRF experiments, respectively. |
![]() |
V34094 | p38α inhibitor 1 | 1034189-82-6 | p38α inhibitor 1 is an inhibitor (blocker/antagonist) of p38α, disclosed in patent WO 2008076265 A1. |
![]() |
V31761 | p5 Ligand for Dnak and DnaJ | 209518-24-1 | p5 Ligand for Dnak and DnaJ is a nonapeptide that corresponds to the primary binding site in the 23-residue portion of the mitochondrial aspartate aminotransferase presequence. |
![]() |
V30436 | p53 17-26 | 488118-64-5 | p53(17-26) is the 17 to 26 amino acid (AA) fragment of p53. |
![]() |
V32197 | P62-mediated mitophagy inducer | 1809031-84-2 | P62-mediated mitophagy inducer (PMI) is a P62-mediated activator of mitosis. |
![]() |
V31122 | PA (224-233), Influenza | 271573-27-4 | PA (224-233), Influenza is a 10-amino acid (AA) polypeptide that is a fragment of the influenza A virus polymerase 2 protein. |